- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 258.66M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 260.16M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 259.16M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$75.28K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$129.46K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$9.27M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$8.83M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$7.81M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$7.11M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.09M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.95K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $132.98K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $110.82K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $265.71K |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $201.86K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $154.33K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$439.2K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$287.96K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$188.65K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$99.14K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $13.22K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $55.19K |
| Revenue | Q1 2025 · Mar 31, 2025 | $27.97K |
| Revenue | Q1 2025 · Mar 31, 2024 | $59.45K |